InsiderSignal.AI

InsiderSignal.ai

IMA - Imagenebio, Inc.

Insider Purchase by Bonita David P (Dir)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

7 months ago, Bonita David P, serving as Dir at Imagenebio, Inc. (IMA), purchased 83,611 shares at $29.90 per share, for a total transaction value of $2,499,969.00. Following this transaction, Bonita David P now holds 774,133 shares of IMA.

This purchase represents a 12.00% increase in Bonita David P's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, July 25, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, July 30, 2025, 5 days after the trade was made.

Imagenebio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Bonita David P

Dir

David P. Bonita, M.D. is a seasoned healthcare investor and board director, currently serving as an Independent Director at ImageneBio, Inc. (IMA) since 2025, alongside roles at Acutus Medical, Inc. (since 2016), Prelude Therapeutics, Inc. (since 2016), Repare Therapeutics, Inc. (since 2019), Third Harmonic Bio, Inc. (since 2020), and others, including as General Partner at OrbiMed Advisors Private Equity since 2020.[[1]](https://www.marketscreener.com/insider/DAVID-BONITA-A077UI/)[[3]](https://preludetx.com/david-bonita-md/)[[4]](https://imagenebio.com/team/david-p-bonita-m-d/) Dr. Bonita previously held directorships at companies such as Tricida, Inc. (until 2023), SI-BONE, Inc. (2014-2019), and Loxo Oncology, Inc. (2013-2017), and began his career as a corporate finance analyst in healthcare investment banking at Morgan Stanley and UBS.[[1]](https://www.marketscreener.com/insider/DAVID-BONITA-A077UI/)[[3]](https://preludetx.com/david-bonita-md/)[[4]](https://imagenebio.com/team/david-p-bonita-m-d/) He holds an A.B. in Biological Sciences from Harvard University (1997) and joint M.D./M.B.A. degrees from Columbia University (2004).[[1]](https://www.marketscreener.com/insider/DAVID-BONITA-A077UI/)[[3]](https://preludetx.com/david-bonita-md/)[[4]](https://imagenebio.com/team/david-p-bonita-m-d/)

View full insider profile →

Trade Price

$29.90

Quantity

83,611

Total Value

$2,499,969.00

Shares Owned

774,133

Trade Date

Friday, July 25, 2025

212 days ago

SEC Filing Date

Wednesday, July 30, 2025

Filed 5 days after trade

HEALTHCAREBIOTECHNOLOGY

About Imagenebio, Inc.

Company Overview

No company information available
View news mentioning IMA

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/92020

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime